WMT
56
-4
AAPL
40
-6
ADBE
47
-9
NWS
75
-4
PGR
59
-3
CFG
74
2
WDC
37
-3
KMI
69
-2
FAST
57
-3
VNO
46
-13
DG
8
-2
BK
74
3
TMO
42
-6
LMT
30
-2
EFX
30
-8
RCL
83
-2
URBN
48
-6
CNP
54
10
AMAT
33
-13
SBUX
37
-2
WMT
56
-4
AAPL
40
-6
ADBE
47
-9
NWS
75
-4
PGR
59
-3
CFG
74
2
WDC
37
-3
KMI
69
-2
FAST
57
-3
VNO
46
-13
DG
8
-2
BK
74
3
TMO
42
-6
LMT
30
-2
EFX
30
-8
RCL
83
-2
URBN
48
-6
CNP
54
10
AMAT
33
-13
SBUX
37
-2
Financhill
Back

Lixte Biotechnology Holdings Vs. Halozyme Therapeutics Industry Stock Comparison

Sell
18

LIXT
Lixte Biotechnology Holdings

Last Price:
1.69
Seasonality Move:
2.1%
Sell
39

HALO
Halozyme Therapeutics

Last Price:
45.65
Seasonality Move:
17.03%
Sell
18
Lixte Biotechnology Holdings (LIXT) is a Sell

Is Lixte Biotechnology Holdings a Buy, Sell or Hold?

  • The current Lixte Biotechnology Holdings [LIXT] share price is $1.62. The Score for LIXT is 18, which is 64% below its historic median score of 50, and infers higher risk than normal.
  • LIXT is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
39
Halozyme Therapeutics (HALO) is a Sell

Is Halozyme Therapeutics a Buy, Sell or Hold?

  • The current Halozyme Therapeutics [HALO] share price is $45.65. The Score for HALO is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
  • HALO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

LIXT Stock Price Chart

What is Lixte Biotechnology Holdings's stock price today?

  • The Lixte Biotechnology Holdings share price today is $1.62
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and LIXT is experiencing selling pressure, which indicates risk of future bearish movement.

HALO Stock Price Chart

What is Halozyme Therapeutics's stock price today?

  • The Halozyme Therapeutics share price today is $45.65
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and HALO is experiencing selling pressure, which indicates risk of future bearish movement.

LIXT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.06 Sell
Relative Strength Index (14 RSI): 43.03 Sell
Chaikin Money Flow: -8867 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (1.6 - 2) Sell
Bollinger Bands (100): (1.76 - 2.26) Sell

HALO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.02 Sell
Relative Strength Index (14 RSI): 30.2 Sell
Chaikin Money Flow: -7140517 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (49.94 - 58.56) Sell
Bollinger Bands (100): (52.16 - 60.38) Sell

LIXT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 1.67 Sell
20-day SMA: 1.79 Sell
50-day SMA: 1.85 Sell
200-day SMA: 2.34 Sell
8-day EMA: 1.68 Sell
20-day EMA: 1.76 Sell
50-day EMA: 1.85 Sell
200-day EMA: 2.35 Sell

HALO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 57.53 Sell
20-day SMA: 54.48 Sell
50-day SMA: 56.18 Sell
200-day SMA: 48.93 Sell
8-day EMA: 55 Sell
20-day EMA: 55.41 Sell
50-day EMA: 55.64 Sell
200-day EMA: 50.73 Sell

Lixte Biotechnology Holdings Earnings Growth & LIXT Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Halozyme Therapeutics Earnings Growth & HALO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.21 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.30 per share, and an increase next year of $0.71 per share.

Lixte Biotechnology Holdings Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Halozyme Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):